Selective agonism
of the estrogen receptor (ER) subtypes, ERα
and ERβ, has historically been difficult to achieve due to the
high degree of ligand-binding domain structural similarity. Multiple
efforts have focused on the use of classical organic scaffolds to
model 17β-estradiol geometry in the design of ERβ selective
agonists, with several proceeding to various stages of clinical development.
Carborane scaffolds offer many unique advantages including the potential
for novel ligand/receptor interactions but remain relatively unexplored.
We synthesized a series of para-carborane estrogen
receptor agonists revealing an ERβ selective structure–activity
relationship. We report ERβ agonists with low nanomolar potency,
greater than 200-fold selectivity for ERβ over ERα, limited
off-target activity against other nuclear receptors, and only sparse
CYP450 inhibition at very high micromolar concentrations. The pharmacological
properties of our para-carborane ERβ selective
agonists measure favorably against clinically developed ERβ
agonists and support further evaluation of carborane-based selective
estrogen receptor modulators.